![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ![]() ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. | ![]() Decibel Therapeutics Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance. | |
Founding Date | Founding Date 2002 | Founding Date 2005 | Founding Date 2015 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations San Clemente, US HQ San Clemente, US | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US | Locations Boston, US HQ |
Employees | Employees 4348% decrease | Employees 5144% decrease | Employees 6810% increase |
Valuation ($) | Valuation ($) 3 m | Valuation ($) 71.2 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $11.3m (FY, 2020) | Revenue (est.) $32m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $5m (FY, 2020) | Cost of goods $4.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $6.3m (FY, 2020) | Gross profit $27.8m (FY, 2025) | Gross profit N/A |
Net income | Net income ($21.6m) (FY, 2020) | Net income ($14m) (FY, 2025) | Net income ($63m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 127m | Total funding raised $ 189m |

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
View company
Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.
View company